Analysen von Richard Vosser
| 21.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 18.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 11.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.16 | Roche overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.06.16 | Roche overweight | JP Morgan Chase & Co. | |
| 31.05.16 | Roche overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.05.16 | Roche overweight | JP Morgan Chase & Co. | |
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 01.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.03.16 | Roche overweight | JP Morgan Chase & Co. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.02.16 | Novartis kaufen | JP Morgan Chase & Co. | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.01.16 | Roche overweight | JP Morgan Chase & Co. | |
| 28.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.01.16 | Roche overweight | JP Morgan Chase & Co. | |
| 11.01.16 | Roche overweight | JP Morgan Chase & Co. | |
| 05.01.16 | Roche overweight | JP Morgan Chase & Co. | |
| 14.12.15 | Roche overweight | JP Morgan Chase & Co. | |
| 03.12.15 | Roche overweight | JP Morgan Chase & Co. | |
| 20.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.11.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 30.10.15 | Bayer overweight | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.10.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.10.15 | Roche overweight | JP Morgan Chase & Co. | |